Nektar Therapeutics (NKTR) Total Debt Growth (3y) (2014 - 2020)
Nektar Therapeutics (NKTR) Total Debt Growth (3y) (2014 - 2020) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Total Debt Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
6.94% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Nektar Therapeutics |
1.51 Bn |
939.55 Mn |
3.16 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2020 |
27.79% |
| Dec 31, 2019 |
1.27% |
| Sep 30, 2019 |
0.72% |
| Jun 30, 2019 |
0.72% |
| Mar 31, 2019 |
0.72% |
| Dec 31, 2018 |
0.72% |
| Sep 30, 2018 |
25.40% |
| Jun 30, 2018 |
25.33% |
| Mar 31, 2018 |
25.26% |
| Dec 31, 2017 |
25.18% |
| Sep 30, 2017 |
25.11% |
| Jun 30, 2017 |
25.03% |
| Mar 31, 2017 |
24.96% |
| Dec 31, 2016 |
24.88% |
| Sep 30, 2016 |
24.81% |
| Jun 30, 2016 |
24.73% |
| Mar 31, 2016 |
24.66% |
| Dec 31, 2015 |
24.58% |
| Sep 30, 2015 |
0.00% |
| Mar 31, 2015 |
-16.53% |
